What a Clinical Hematologist Should Know about T Cells?

Main Article Content

Sanjeev Kumar Sharma


T cell’s journey begins from the bone marrow and ends in the peripheral tissues by either fighting the infections or residing in the secondary lymphoid organs as memory T cell. Thymus plays most important role in transforming a docile T cell precursor into a warrior. T cell is one of the most important cells in health and disease. Various diseases originate from qualitative or quantitative defects in T cells leading to various inherited and acquired diseases. This simple and short review is focused on the basic understanding and clinical hematologist’s perspective of T cells.

T cells, thymus, T cell receptor, autoimmune diseases, severe combined immunodeficiency, hematopoietic stem cell transplant, graft-versus-host disease, leukemia, lymphoma, aging, CAR-T cell, checkpoint inhibitors.

Article Details

How to Cite
Sharma, S. K. (2020). What a Clinical Hematologist Should Know about T Cells?. International Blood Research & Reviews, 11(4), 20-32. https://doi.org/10.9734/ibrr/2020/v11i430137
Minireview Article


Kumar BV, Connors T, Farber DL. Human T cell development, localization, and function throughout life. Immunity. 2018; 48(2):202–13.

Gaspar H, Gilmour K, Jones A. Severe combined immunodeficiency—molecular pathogenesis and diagnosis. Arch Dis Child. 2001;84(2):169–73.

Pizzi M, Margolskee E, Inghirami G. Pathogenesis of peripheral T cell lymphoma. Annu Rev Pathol Mech Dis. 2018;13(1):293–320.

Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359(6382):1350–5.

Ando T, Tachibana T, Tanaka M, Suzuki T, Ishiyama Y, Koyama S, et al. Impact of graft sources on immune reconstitution and survival outcomes following allogeneic stem cell transplantation. Blood Adv. 2020; 4(2):408–19.

Pangrazzi L, Weinberger B. T cells, aging and senescence. Exp Gerontol. 2020;134: 110887.

Charles A Janeway J, Travers P, Walport M, Shlomchik MJ. Generation of lymphocytes in bone marrow and thymus. Immunobiol Immune Syst Health Dis 5th Ed [Internet]; 2001. Available:https://www.ncbi.nlm.nih.gov/books/NBK27123

Bhandoola A, von Boehmer H, Petrie HT, Zúñiga-Pflücker JC. Commitment and developmental potential of extrathymic and intrathymic T cell precursors: Plenty to choose from. Immunity. 2007;26(6):678–89.

Takahama Y. Journey through the thymus: Stromal guides for T-cell development and selection. Nat Rev Immunol. 2006;6(2): 127–35.

Lythe G, Callard RE, Hoare RL, Molina-París C. How many TCR clonotypes does a body maintain? J Theor Biol. 2016;389: 214–24.

Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Lymphocytes and the cellular basis of adaptive immunity. Mol Biol Cell 4th Ed [Internet]; 2002. Available:https://www.ncbi.nlm.nih.gov/books/NBK26921

Gardner JM, Fletcher AL, Anderson MS, Turley SJ. AIRE in the thymus and beyond. Curr Opin Immunol. 2009;21(6):582–9.

Perniola R. Twenty Years of AIRE. Front Immunol [Internet]; 2018. Available:https://www.frontiersin.org/articles/10.3389/fimmu.2018.00098

Derbinski J, Kyewski B. How thymic antigen presenting cells sample the body’s self-antigens. Curr Opin Immunol. 2010; 22(5):592–600.

Pennock ND, White JT, Cross EW, Cheney EE, Tamburini BA, Kedl RM. T cell responses: Naïve to memory and everything in between. Adv Physiol Educ. 2013;37(4):273–83.

Chatila TA. Role of regulatory T cells in human diseases. J Allergy Clin Immunol. 2005;116(5):949–59.

Workman CJ, Szymczak-Workman AL, Collison LW, Pillai MR, Vignali DAA. The Development and Function of Regulatory T Cells. Cell Mol Life Sci. 2009;66(16):2603–22.

Vignali DAA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8(7):523–32.

Garrido F, Perea F, Bernal M, Sánchez-Palencia A, Aptsiauri N, Ruiz-Cabello F. The escape of cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture. Vaccines [Internet]. 2017;5(1). Available:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371743

Su LF, Alcazar D del, Stelekati E, Wherry EJ, Davis MM. Antigen exposure shapes the ratio between antigen-specific Tregs and conventional T cells in human peripheral blood. Proc Natl Acad Sci. 2016; 113(41):6192–98.

Gellert M. V(D)J Recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem. 2002;71(1):101–32.

McBride JA, Striker R. Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health? PLoS Pathog [Internet]. 2017;13(11). Available:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667733

Hadrup SR, Strindhall J, Køllgaard T, Seremet T, Johansson B, Pawelec G, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol. 2006;176(4):2645–53.

Okoye AA, Picker LJ. CD4+ T cell depletion in HIV infection: Mechanisms of immunological failure. Immunol Rev. 2013; 254(1):54–64.

Grant SM, Lou M, Yao L, Germain RN, Radtke AJ. The lymph node at a glance – how spatial organization optimizes the immune response. J Cell Sci [Internet]. 2020;133(5). Available:https://jcs.biologists.org/content/133/5/jcs241828

Moore JE, Bertram CD. Lymphatic System Flows. Annu Rev Fluid Mech. 2018;50: 459–82.

Matson DR, Yang DT. Autoimmune lymphoproliferative syndrome: An Overview. Arch Pathol Lab Med. 2020; 144(2):245–51.

Claman HN, Chaperon EA, Triplett RF. Thymus-marrow cell combinations. Synergism in antibody production. Proc Soc Exp Biol Med Soc. 1966;122(4):1167–71.

Crotty S. A brief history of T cell help to B cells. Nat Rev Immunol. 2015;15(3):185–9.

Martínez-Lostao L, Anel A, Pardo J. How do cytotoxic lymphocytes kill cancer cells? Clin Cancer Res. 2015;21(22):5047–56.

Villa A, Notarangelo LD, Roifman CM. Omenn syndrome: Inflammation in leaky severe combined immunodeficiency. J Allergy Clin Immunol. 2008;122(6):1082–6.

Milićević NM, Nohroudi K, Milićević Ž, Hedrich HJ, Westermann J. T cells are required for the peripheral phase of B-cell maturation. Immunology. 2005;116(3): 308–17.

Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001; 27(1):20–1.

Forman SJ, Negrin RS, Antin JH, Appelbaum FR. Thomas’ hematopoietic cell transplantation: Stem cell transplantation. John Wiley & Sons; 2015.

Kassim AA, Chinratanalab W, Ferrara JLM, Mineishi S. Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: “What is the best recipe?” Bone Marrow Transplant. 2005;36(7):565–74.

Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem HP, et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood. 1997;89(8):3048–54.

Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia. 2007;21(7):1387–94.

Gaspar HB, Qasim W, Davies EG, Rao K, Amrolia PJ, Veys P. How I treat severe combined immunodeficiency. Blood. 2013; 122(23):3749–58.

Gaballa A, Sundin M, Stikvoort A, Abumaree M, Uzunel M, Sairafi D, et al. T Cell Receptor Excision Circle (TREC) monitoring after allogeneic stem cell transplantation; A predictive marker for complications and clinical outcome. Int J Mol Sci [Internet]. 2016;17(10). Available:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085737

Muraro PA, Douek DC, Packer A, Chung K, Guenaga FJ, Cassiani-Ingoni R, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med. 2005; 201(5):805–16.

de Kleer I, Vastert B, Klein M, Teklenburg G, Arkesteijn G, Yung GP, et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood. 2006; 107(4):1696–702.

Chaudhry MS, Velardi E, Dudakov JA, van den Brink MRM. Thymus: The next (re)generation. Immunol Rev. 2016;271(1): 56–71.

Fletcher AL, Lowen TE, Sakkal S, Reiseger JJ, Hammett MV, Seach N, et al. Ablation and regeneration of tolerance-inducing medullary thymic epithelial cells after cyclosporine, cyclophosphamide, and dexamethasone treatment. J Immunol. 2009;183(2):823–31.

Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol. 1996;156(12):4609–16.

Mackall CL. T-cell immunodeficiency following cytotoxic antineoplastic therapy: A review. Stem Cells Dayt Ohio. 2000; 18(1):10–8.

Seggewiss R, Einsele H. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: An update. Blood. 2010;115(19):3861–8.

Krenger W, Blazar BR, Holländer GA. Thymic T-cell development in allogeneic stem cell transplantation. Blood. 2011; 117(25):6768–76.

Lopes N, Sergé A, Ferrier P, Irla M. Thymic crosstalk coordinates medulla organization and T-cell tolerance induction. Front Immunol [Internet]. 2015;6. Available:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507079

Capalbo D, Giardino G, Martino LD, Palamaro L, Romano R, Gallo V, et al. Genetic basis of altered central tolerance and autoimmune diseases: A lesson from AIRE mutations. Int Rev Immunol. 2012; 31(5):344–62.

Cooke KR, Luznik L, Sarantopoulos S, Hakim FT, Jagasia M, Fowler DH, et al. The biology of chronic graft-versus-host disease: A task force report from the National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2017; 23(2):211–34.

Sharma SK, Choudhary D, Doval D, Khandelwal V, Patel A, Setia R, et al. Myeloablative versus reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplant for acute myeloid leukemia and myelodysplastic syndrome: A retrospective analysis. Indian J Hematol Blood Transfus [Internet]; 2020. Available:https://doi.org/10.1007/s12288-020-01386-6

Young NS. Current concepts in the pathophysiology and treatment of aplastic anemia. Hematol Am Soc Hematol Educ Program. 2013;2013:76–81.

Shi J, Ge M, Lu S, Li X, Shao Y, Huang J, et al. Intrinsic impairment of CD4(+)CD25(+) regulatory T cells in acquired aplastic anemia. Blood. 2012; 120(8):1624–32.

Buckner JH. Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases. Nat Rev Immunol. 2010;10(12): 849–59.

Swerdlow S, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues [Internet]; 2008. Available:https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/WHO-Classification-Of-Tumours-Of-Haematopoietic-And-Lymphoid-Tissues-2017

Bell JJ, Bhandoola A. The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature. 2008;452(7188): 764–7.

Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–90.

Teuffel O, Kuster SP, Hunger SP, Conter V, Hitzler J, Ethier MC, et al. Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: A systematic review and meta-analysis. Leukemia. 2011;25(8):1232–8.

Przepiorka D, LeParc GF, Stovall MA, Werch J, Lichtiger B. Use of irradiated blood components: Practice parameter. Am J Clin Pathol. 1996;106(1):6–11.

Rohaan MW, Wilgenhof S, Haanen JBAG. Adoptive cellular therapies: the current landscape. Virchows Arch Int J Pathol. 2019;474(4):449–61.

Dotti G, Gottschalk S, Savoldo B, Brenner MK. Design and development of therapies using chimeric antigen receptor-expressing T cells. Immunol Rev [Internet]. 2014; 257(1). Available:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874724

Schuster SJ, Svoboda J, Chong EA, Nasta SD, Mato AR, Anak Ö, et al. Chimeric antigen receptor T cells in refractory B-cell lymphomas. N Engl J Med. 2017;377(26): 2545–54.

Hui E. Immune checkpoint inhibitors. J Cell Biol. 2019;218(3):740–1.

Alatrash G, Daver N, Mittendorf EA. Targeting immune checkpoints in hematologic malignancies. Pharmacol Rev. 2016;68(4):1014–25.